表紙
市場調査レポート

eクリニカルソリューションの世界市場予測 2020年:臨床データ管理システム(CDMS)、電子データキャプチャー (EDC)、臨床試験管理システム (CTMS)、電子臨床転帰評価 (eCOA)、電子治験マスターファイル (eTMF)、ほか

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web Hosted, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 249136
出版日 ページ情報 英文 161 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
eクリニカルソリューションの世界市場予測 2020年:臨床データ管理システム(CDMS)、電子データキャプチャー (EDC)、臨床試験管理システム (CTMS)、電子臨床転帰評価 (eCOA)、電子治験マスターファイル (eTMF)、ほか eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web Hosted, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2020
出版日: 2016年02月04日 ページ情報: 英文 161 Pages
概要

世界のeクリニカルソリューション市場は、2015年から2020年にかけて12.1%のCAGR (年間複合成長率) で成長すると予測されています。北米および欧州といった先進地域が2015年のeクリニカルソリューション市場において大きなシェアを保有しているものの、アジア太平洋地域は今後5年間で16.1%のCAGRで成長する構えを示しています。アジア太平洋諸国における大手医薬品・バイオ医薬品企業による治験アウトソーシングの増加、大規模な患者人口の存在、および治験を行う上での低いオペレーションコストといった要因は、同地域におけるeクリニカルソリューション市場の成長を加速させています。

当レポートは、世界のeクリニカルソリューション市場について調査し、製品、デリバリー形態、治験段階、およびエンドユーザー別による市場の分析、4つの主要地域における市場分析、および主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力の評価などについて、まとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • eクリニカルソリューション市場概要
  • eクリニカルソリューション市場規模:製品別
  • 地域分析:eクリニカルソリューション市場、デリバリー形態別
  • eクリニカルソリューション市場シェア:治験段階別
  • eクリニカルソリューション市場:エンドユーザー・地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場ダイナミクス
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 eクリニカルソリューション市場:製品別

  • イントロダクション
  • 電子データキャプチャー (EDC) および臨床データ管理システム(CDMS)
  • 臨床試験管理システム (CTMS)
  • 臨床分析プラットフォーム
  • 無作為化及び治験サプライ管理 (RTSM)
  • 臨床データ統合プラットフォーム
  • 電子臨床転帰評価 (eCOA)
  • 安全性ソリューション
  • 電子治験マスターファイル (eTMF)
  • その他のeクリニカルソリューション

第7章 eクリニカルソリューション市場:デリバリー形態別

  • イントロダクション
  • ウェブホステッド (オンデマンド)
  • 認可企業 (オンプレミス)
  • クラウド型 (SaaS)

第8章 eクリニカルソリューション市場:治験段階別

  • イントロダクション
  • 第I相
  • 第II相
  • 第III相
  • 第IV相

第9章 eクリニカルソリューション市場:エンドユーザー別

  • 医薬品・バイオ医薬品企業
  • 医薬品開発業務受託機関 (CRO)
  • コンサルティングサービス企業
  • 医療機器メーカー
  • 病院
  • 学問研究機関

第10章 eクリニカルソリューション市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第12章 企業プロファイル (概要・財務・製品&サービス・戦略・開発)

  • イントロダクション
  • ORACLE CORPORATION
  • MEDIDATA SOLUTIONS, INC.
  • PAREXEL INTERNATIONAL CORPORATION
  • BIOCLINICA, INC. (A SUBSIDIARY OF JLL PARTNERS)
  • DATATRAK INTERNATIONAL, INC.
  • CRF HEALTH
  • ERT
  • ECLINICAL SOLUTIONS, INC.
  • MERGE HEALTHCARE INCORPORATED
  • OMNICOMM SYSTEMS, INC.

第13章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HIT 2208

The global eClinical solutions market is estimated to grow at a high CAGR of 12.1% from 2015 to 2020. Although developed regions (such as North America and Europe) held large shares in the eClinical solutions market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 16.1% in the next five years. Factors such as the increasing outsourcing of clinical trial studies by the large pharma and biopharma companies in Asia-Pacific countries, presence of large patient population, and low operating cost in conducting clinical trials are propelling the growth of the eClinical solutions market in this region.

The growth of the global eClinical solutions market is driven by factors such as rising adoption of software solutions during clinical trials, increasing R&D expenditure by pharmaceutical companies, growing government grants to support clinical research, and rising customer base. In addition, increasing clinical research in emerging Asian countries, shift of clinical trials and resources from AMCs to CROs, and developments of cost effective modules are offering new growth opportunities for the eClinical solutions vendors. Nonetheless, the high implementation cost, dearth of skilled research professionals, and lack of awareness of clinical data sciences software in research community are the key reasons hampering the growth of the eClinical solutions market. Besides, low software adoption rate in several geographic such as Middle East and Africa, and software reliability and patient privacy issues are also restricting the growth of the eClinical solutions market.

In this report, the eClinical solutions market has been segmented on the basis of product (covering electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platform, randomization & trial supply management systems (RTMS), clinical data integration platforms, electronic clinical outcome assessment (eCOA), safety solutions, electronic trail master files (eTMF), and others (regulatory information management solutions, coding systems, and core laboratory integration solutions); delivery mode (including web-hosted (On-demand), licensed enterprise (On-premise), cloud-based (SaaS); clinical trial phase (phase I, phase II, phase III, and phase IV); end user (pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions); and region (North America, Europe, Asia-Pacific, and the Rest of the World). The EDC and CDMS segment is estimated to account for the largest share of the global eClinical solutions market in 2015. However, the eCOA segment is expected to grow at the highest CAGR during the forecast period. Increasing demand for eDiaries in clinical studies to collect patient self-reports by major pharmaceutical companies and rising adoption of mobile and digital technologies are driving the growth of this market segment.

Geographically, North America is estimated to command the largest share of 59.6% of the global eClinical solutions market in 2015, followed by Europe. The large market share of the North American region is attributed to the significantly large number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, growth in the number of partnerships for new drug development, and high prevalence of lifestyle diseases with increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting clinical trials in the North American region are negatively affecting the growth of the eClinical solutions market in this region.

The eClinical solutions market is highly competitive, with a large number of global and local providers of eClinical solutions. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2014. These companies together accounted for 44.9% of the global market. Partnerships, agreements, and collaborations; product launches and product enhancements; product deployments; mergers and acquisitions; and geographic expansions are the major strategies adopted by most of the market players to achieve growth in the eClinical solutions market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis -market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the eClinical solutions market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on eClinical solutions offered by the top 10 players in the eClinical solutions market. The report analyzes the eClinical solutions market by product, delivery mode, clinical trial phase, and end users across four geographies
  • Product Development/Innovation: Detailed insights on current technologies, research and development activities, and new product launches in the eClinical solutions market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various eClinical solutions across four geographies (North America, Europe, Asia-Pacific, and Rest of the World)
  • Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the eClinical solutions market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
      • 2.2.1.1. Bottom-up approach
      • 2.2.1.2. Top-down approach
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. eCLINICAL SOLUTIONS MARKET OVERVIEW
  • 4.2. eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020. (USD MILLION)
  • 4.3. GEOGRAPHIC ANALYSIS: eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015
  • 4.4. eCLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2015. VS. 2020
  • 4.5. eCLINICAL SOLUTIONS MARKET, BY END USER AND REGION, 2015

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Growing adoption of software solutions during clinical trials
      • 5.3.1.2. Government grants to support clinical trials
      • 5.3.1.3. Need for improved data standardization
      • 5.3.1.4. Increasing research and development expenditure by pharmaceutical companies
      • 5.3.1.5. Growing customer base
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High implementation costs
      • 5.3.2.2. Dearth of skilled research professionals
      • 5.3.2.3. Lack of awareness
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Increasing clinical research activities in emerging Asian countries
      • 5.3.3.2. Increasing outsourcing of clinical trials to CROs
      • 5.3.3.3. Development of cost-effective modules
      • 5.3.3.4. Rising number of clinical trials
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Low adoption
      • 5.3.4.2. Software reliability
      • 5.3.4.3. Patient privacy

6. eCLINICAL SOLUTIONS MARKET, BY PRODUCT 46

  • 6.1. INTRODUCTION
  • 6.2. ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS)
  • 6.3. CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)
  • 6.4. CLINICAL ANALYTICS PLATFORMS
  • 6.5. RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)
  • 6.6. CLINICAL DATA INTEGRATION PLATFORMS
  • 6.7. ELECTRONIC CLINICAL OUTCOME ASSESSMENT (eCOA)
  • 6.8. SAFETY SOLUTIONS
  • 6.9. ELECTRONIC TRIAL MASTER FILE (eTMF)
  • 6.10. OTHER ECLINICAL SOLUTIONS

7. eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 64

  • 7.1. INTRODUCTION
  • 7.2. WEB-HOSTED (ON-DEMAND)
  • 7.3. LICENSED ENTERPRISE (ON-PREMISE)
  • 7.4. CLOUD-BASED (SAAS)

8. eCLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 70

  • 8.1. INTRODUCTION
  • 8.2. PHASE I
  • 8.3. PHASE II
  • 8.4. PHASE III
  • 8.5. PHASE IV

9. eCLINICAL SOLUTIONS MARKET, BY END USER 80

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 9.3. CONTRACT RESEARCH ORGANIZATIONS
  • 9.4. CONSULTING SERVICE COMPANIES
  • 9.5. MEDICAL DEVICE MANUFACTURERS
  • 9.6. HOSPITALS
  • 9.7. ACADEMIC RESEARCH INSTITUTES

10. eCLINICAL SOLUTIONS MARKET, BY REGION 90

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA-PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.3.2. NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
    • 11.3.3. PRODUCT DEPLOYMENT
    • 11.3.4. MERGERS AND ACQUISITIONS
    • 11.3.5. EXPANSION
    • 11.3.6. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 12.1. INTRODUCTION
  • 12.2. ORACLE CORPORATION
  • 12.3. MEDIDATA SOLUTIONS, INC.
  • 12.4. PAREXEL INTERNATIONAL CORPORATION
  • 12.5. BIOCLINICA, INC. (A SUBSIDIARY OF JLL PARTNERS)
  • 12.6. DATATRAK INTERNATIONAL, INC.
  • 12.7. CRF HEALTH
  • 12.8. ERT
  • 12.9. ECLINICAL SOLUTIONS, INC.
  • 12.10. MERGE HEALTHCARE INCORPORATED
  • 12.11. OMNICOMM SYSTEMS, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE*
  • 13.2. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: U.S.: LIST OF SOME LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 & 2014
  • TABLE 2: GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 3: GLOBAL ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 4: NORTH AMERICA: ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 5: GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 7: GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 9: GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 11: GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 13: GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: GLOBAL ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE (ETMF) MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: GLOBAL OTHER eCLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: NORTH AMERICA: OTHER eCLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2013-2020 (USD MILLION)
  • TABLE 22: WEB-HOSTED (ON-DEMAND) eCLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: LICENSED ENTERPRISE (ON-PREMISE) eCLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: CLOUD-BASED (SAAS) eCLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION)
  • TABLE 26: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 35: eCLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: EXAMPLES OF STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES
  • TABLE 37: eCLINICAL SOLUTIONS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: eCLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: eCLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: eCLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: eCLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: eCLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 45: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 46: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION)
  • TABLE 47: NORTH AMERICA: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 48: U.S.: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 49: U.S.: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION)
  • TABLE 50: CANADA: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 51: CANADA: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION)
  • TABLE 52: EUROPEAN MEDICINES AGENCY (EMA)-APPROVED BIOSIMILARS
  • TABLE 53: EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 61: ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 62: ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 63: ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: eCLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 65: TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2015
  • TABLE 66: TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2013-2015
  • TABLE 67: TOP 5 PRODUCT DEPLOYMENTS, 2013-2015
  • TABLE 68: TOP 5 MERGERS AND ACQUISITIONS, 2013-2015
  • TABLE 69: EXPANSIONS, 2013-2015
  • TABLE 70: TOP 5 OTHER DEVELOPMENTS, 2013-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: eCLINICAL SOLUTIONS MARKET: END-USER ANALYSIS APPROACH
  • FIGURE 4: eCLINICAL SOLUTIONS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: eCLINICAL SOLUTIONS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: eCLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
  • FIGURE 7: GLOBAL eCLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015 (USD MILLION)
  • FIGURE 8: GLOBAL eCLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015 VS. 2020
  • FIGURE 9: GLOBAL eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015 VS. 2020
  • FIGURE 10: GLOBAL eCLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 11: GLOBAL eCLINICAL SOLUTIONS MARKET, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 12: GLOBAL eCLINICAL SOLUTIONS MARKET, BY REGION, 2015 (USD MILLION)
  • FIGURE 13: EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES
  • FIGURE 14: EDC & CDMS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET IN 2020
  • FIGURE 15: WEB-HOSTED DELIVERY MODE SEGMENT DOMINATES THE GLOBAL eCLINICAL SOLUTIONS MARKET IN ALL REGIONAL SEGMENTS
  • FIGURE 16: PHASE III CLINICAL TRIALS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET IN 2020
  • FIGURE 17: ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS MARKET IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE BETWEEN 2015 AND 2020
  • FIGURE 18: eCLINICAL SOLUTIONS MARKET SEGMENTATION
  • FIGURE 19: eCLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: THE EDC AND CDMS SEGMENT TO COMMAND THE LARGEST SHARE OF THE GLOBAL eCLINICAL SOLUTIONS MARKET IN 2015
  • FIGURE 21: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE EDC AND CDMS MARKET IN 2015
  • FIGURE 22: ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) MARKET DURING THE FORECAST PERIOD
  • FIGURE 23: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE CLINICAL ANALYTICS PLATFORMS MARKET IN 2015
  • FIGURE 24: ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) MARKET
  • FIGURE 25: WEB-HOSTED (ON-DEMAND) SEGMENT TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET IN ALL REGIONS IN 2015
  • FIGURE 26: PHASE III TRIALS IS THE FASTEST-GROWING MARKET SEGMENT IN THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA TO DOMINATE THE GLOBAL eCLINICAL SOLUTIONS MARKET FOR PHASE I CLINICAL TRIALS IN 2015
  • FIGURE 28: ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE eCLINICAL SOLUTIONS MARKET FOR PHASE II TRIALS
  • FIGURE 29: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE GLOBAL eCLINICAL SOLUTIONS MARKET FOR PHASE III TRIALS IN 2015
  • FIGURE 30: ASIA-PACIFIC OFFERS HIGH GROWTH OPPORTUNITIES FOR THE PLAYERS IN THE eCLINICAL SOLUTIONS MARKET FOR PHASE IV TRIALS
  • FIGURE 31: GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2015
  • FIGURE 32: R&D EXPENDITURE OF THE TOP 10 PHARMACEUTICAL COMPANIES, 2013 VS. 2014 (USD MILLION)
  • FIGURE 33: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST SEGMENT OF THE GLOBAL eCLINICAL SOLUTIONS MARKET FOR PHARMA AND BIOPHARMA COMPANIES IN 2015
  • FIGURE 34: ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING REGION IN THE eCLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS
  • FIGURE 35: GLOBAL eCLINICAL SOLUTIONS MARKET: MARKET SIZE & GROWTH FORECAST, BY REGION (2015-2020)
  • FIGURE 36: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 37: EUROPE: eCLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 38: EUROPE: NUMBER OF BIOSIMILAR APPROVALS, 2006-2014
  • FIGURE 39: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY (2012)
  • FIGURE 40: ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 41: GLOBAL eCLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2014
  • FIGURE 42: BATTLE FOR MARKET SHARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, THE KEY GROWTH STRATEGY FOR MARKET PLAYERS
  • FIGURE 43: GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS
  • FIGURE 44: ORACLE CORPORATION: COMPANY SNAPSHOT
  • FIGURE 45: MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT
  • FIGURE 46: PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
  • FIGURE 47: DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • FIGURE 48: MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 49: OMNICOMM SYSTEMS, INC.: COMPANY SNAPSHOT
Back to Top